The global surface protein gp120 market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Surface proteins are proteins that are found on the layer of cell membranes of more complex organisms and are integral to how a cell interacts with the environment around it along with other cells. Additionally, one of the main components of the HIV-1 vaccine is gp120. The major factor accelerating the growth of the market is the increasing prevalence of HIV across the globe.
According to the UNAIDS, in 2020, an estimated 37.7 million or 30.2 million–45.1 million people were living with HIV globally. Additionally, in the same year, an estimated 1.5 million or 1.0 million–2.0 million new cases of HIV were found. Furthermore, in 2020, there was a mortality rate of an estimated 680,000 or 480,000–1.0 million from AIDS-related illnesses. Moreover, since the start of the epidemic, an estimated 79.3 million or 55.9 million–110 million people have become infected with HIV. Hence, the increasing prevalence of this disease is driving the demand for surface protein gp120 due to its application in the HIV vaccine which in turn is driving the growth of the market.
To Request a Sample of our Report on Surface Protein gp120 Market: https://www.omrglobal.com/request-sample/surface-protein-gp-120-market
Some major players in the market include GlaxoSmithKline Plc, and Sanofi SA, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2020, GlaxoSmithKline plc announced the approval of Rukobia from the US FDA. It is used for the treatment of patients resistant to multiple HIV drugs by latching onto the gp120 protein on the surface of HIV while blocking the virus from entering and infecting immune cells.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- GlaxoSmithKline Plc, and Sanofi SA, among others.
(Get 15% Discount on Buying this Report)
A full Report of Surface Protein gp120 Market is Available @ https://www.omrglobal.com/industry-reports/surface-protein-gp-120-market
Global Surface Protein gp120 Market Report by Segment
By Type
- DS-003
- BMD-104
- HNG-156
- M-48U1
- Others
By Application
- Clinic
- Hospital
- Others
Global Surface Protein gp120 Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
